NCT00495014View on ClinicalTrials.gov

Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

GSK376501

DRUG

Placebo

Trial Locations (1)

47714

GSK Investigational Site, Evansville

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY